Select Your Country or Region

You are now at UK (English)
Home / Products / Pressure Ulcer Prevention / Pressure Ulcer Risk Assessment

Pressure Ulcer Prevention

Provizio SEM Scanner

Deliver objective and anatomically-specific assessment of pressure ulcer (PI) risk 5 days*¹ earlier than visual skin assessment, regardless of skin tone². This empowers you with a window of opportunity to deploy a tailored prevention strategy to minimise PI incidence.

Provizio SEM Scanner (39)

Request a demonstration

Experience the Provizio SEM Scanner and see how it supports you to get ahead of pressure ulcers.

Proven to support significant reductions in PI incidence across care settings³

47%

 

in hospice settings​

90%​

(weighted average)​

in acute care settings​​

27%

 

in community care​​

Recognised in the latest EPUAP-NPIAP-PPPIA international guidelines⁴

Recommendation 2.6

 

“Consider using a sub-epidermal moisture/edema measurement device as an adjunct to routine clinical skin assessment”


(Strength of Evidence = B2, Strength of recommendation ↔)

 

Recommendation 2.7

 

“When assessing darkly pigmented skin, consider assessment of sub-epidermal moisture as important adjunct strategy”


(Strength of Evidence = B2, Strength of recommendation ↑)

 

The Science of Sub-epidermal Moisture (SEM)

Elevated levels of SEM is a biomarker of early tissue damage that can lead to pressure ulcer development. SEM can be identified by assessing the biocapacitance of tissue. This non-invasive technology enables early and objective assessment of increased pressure ulcer (PI) risk, empowering you to take decisive action to minimise PI incidence and to help reduce overall cost and time to care.
Science of SEM image

Find out more about the role of SEM in pressure ulcer development​

Download our clinical evidence summary.

Provizio SEM Scanner (60)

Provizio® SEM Scanner

Visit the product page for specifications, downloads and more.​

Early and Targeted Intervention is key

Our pressure ulcer prevention solutions support you in setting a new standard of clinical excellence by:

• Ensuring early, objective, and anatomically specific risk assessment
• Offering comprehensive solutions to enable tailored intervention
• Driving and sustaining improved clinical outcomes

Arjo.AtmosAir Velaris 9000X Enterprise (3).tif

The Arjo Pressure Ulcer Prevention portfolio

From support surfaces and microclimate management to early and objective risk identification, we offer market leading innovations designed to support your pressure ulcer prevention and management in all care settings.

Auralis (43)

Join our mailing list

To receive updates on clinical evidence, case studies, webinars by industry thought leaders and more supporting pressure ulcer prevention across all care settings.

*Median

Copyright, trademarks and logos are the intellectual property of Bruin Biometrics LLC, this includes the following: Provizio® SEM Scanner and SEM Scanner®. Bruin Biometrics LLCs copyright materials cannot be used or reproduced without Bruin Biometrics LLCs written consent.